Lis William's Form 4 filing
Jasper Therapeutics, Inc. (JSPR) · filed Jun 28, 2022
- Accession no.
- 0001213900-22-035570
- Filed
- Jun 28, 2022
- Trade date
- Jun 24-27, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $101.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lis WilliamCIK 0001574558 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2022 | Voting Common Stock | SSaleDisposed | −24,743 | $2.02 | −$49,980.86 | 65,229 | Direct | |
| Jun 27, 2022 | Voting Common Stock | SSaleDisposed | −24,743 | $2.08 | −$51,465.44 | 40,486 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.